Emerging Hyperprolactinemic Galactorrhea in Obsessive Compulsive Disorder with a Stable Dose of Fluoxetine
Clinical Psychopharmacology and Neuroscience
;
: 316-318, 2015.
Artículo
en Inglés
| WPRIM
| ID: wpr-209620
ABSTRACT
While fluoxetine (FXT) is a frequently prescribed selective serotonin reuptake inhibitor (SSRI), with few major side-effects; altered serotonergic transmissions in hypothalamic pathways might lead to a distressing, and often embarrassing, manifestation of galactorrhea by altering prolactin release in those on FXT. We report here a case of FXT-induced hyperprolactinemic galactorrhea developing late into treatment on a stable regimen, who responded well to subsequent replacement with sertraline. Based on present finding, we suggest that while SSRIs may share similar mechanisms of action, there exist individual differences in their effects on prolactin secretion pathways.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Prolactina
/
Hiperprolactinemia
/
Serotonina
/
Fluoxetina
/
Inhibidores Selectivos de la Recaptación de Serotonina
/
Sertralina
/
Vías Secretoras
/
Galactorrea
/
Individualidad
/
Trastorno Obsesivo Compulsivo
Límite:
Embarazo
Idioma:
Inglés
Revista:
Clinical Psychopharmacology and Neuroscience
Año:
2015
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS